PERP B Stock Overview
Provides products and solutions for use of injectable drugs in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Perpetua Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 4.30 |
| 52 Week High | SEK 5.45 |
| 52 Week Low | SEK 1.01 |
| Beta | 2.08 |
| 1 Month Change | -11.89% |
| 3 Month Change | 4.47% |
| 1 Year Change | 316.67% |
| 3 Year Change | -98.05% |
| 5 Year Change | -97.63% |
| Change since IPO | -99.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| PERP B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -4.4% | 0.4% | -2.7% |
| 1Y | 316.7% | -8.1% | 4.6% |
Return vs Industry: PERP B exceeded the Swedish Medical Equipment industry which returned -8.1% over the past year.
Return vs Market: PERP B exceeded the Swedish Market which returned 4.6% over the past year.
Price Volatility
| PERP B volatility | |
|---|---|
| PERP B Average Weekly Movement | 10.2% |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.3% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: PERP B's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: PERP B's weekly volatility has decreased from 20% to 10% over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 1 | Anders Hedlund | perpetuamedical.se |
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. The company offers DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company formerly known as Pharmacolog i Uppsala AB (publ) and changed its name to Perpetua Medical AB (publ) in April 2024.
Perpetua Medical AB (publ) Fundamentals Summary
| PERP B fundamental statistics | |
|---|---|
| Market cap | SEK 19.44m |
| Earnings (TTM) | -SEK 5.18m |
| Revenue (TTM) | SEK 5.34m |
3.6x
P/S Ratio-3.8x
P/E RatioIs PERP B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PERP B income statement (TTM) | |
|---|---|
| Revenue | SEK 5.34m |
| Cost of Revenue | SEK 2.78m |
| Gross Profit | SEK 2.56m |
| Other Expenses | SEK 7.74m |
| Earnings | -SEK 5.18m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
| Earnings per share (EPS) | -1.15 |
| Gross Margin | 47.89% |
| Net Profit Margin | -96.95% |
| Debt/Equity Ratio | 33.1% |
How did PERP B perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 06:47 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Perpetua Medical AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Niklas Elmhammer | Carlsquare AB |